glycyrrhizic acid has been researched along with AIDS, Murine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abo, T; Makino, M; Miyaji, C; Watanbe, H | 1 |
| Ito, M; Kobayashi, M; Pollard, RB; Suzuki, F; Utsunomiya, T | 1 |
2 other study(ies) available for glycyrrhizic acid and AIDS, Murine
| Article | Year |
|---|---|
Therapeutic effects of glycyrrhizin in mice infected with LP-BM5 murine retrovirus and mechanisms involved in the prevention of disease progression.
Topics: Animals; Antiviral Agents; Body Weight; CD3 Complex; Cysteine; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Immunophenotyping; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Splenomegaly | 1996 |
Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responses.
Topics: AIDS-Related Opportunistic Infections; Animals; Antibodies, Monoclonal; Antibody Formation; Antifungal Agents; Candida albicans; Candidiasis; CD4-Positive T-Lymphocytes; Disease Susceptibility; Glycyrrhizic Acid; Immunity, Innate; Interleukin-10; Interleukin-4; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Th2 Cells | 2000 |